Efficacy of combined approaches of periocular reconstruction and dermatologic treatment in the management of invasive cutaneous malignant neoplasm: a systematic review of functional and cosmetic outcomes
DOI:
https://doi.org/10.56183/iberojhr.v5i1.756Palavras-chave:
Periocular reconstruction, Dermatologic treatment, Invasive cutaneous malignant neoplasm.Resumo
Background: The periocular region is a high-risk site for cutaneous malignancies, particularly basal and squamous cell carcinomas. Because of its role in protecting the eye and supporting tear film dynamics, even small defects in this area can disrupt function and lead to noticeable cosmetic changes. Managing tumors here requires a careful balance between complete cancer removal and preserving eyelid function and appearance. Objective: To evaluate the functional and cosmetic outcomes of combining periocular reconstruction with dermatologic and systemic treatments in patients with invasive periocular skin cancers. Methods: We conducted a systematic review of 57 studies involving patients with invasive cutaneous malignancies of the periocular region. Included treatments spanned Mohs micrographic surgery (MMS), conventional excision with frozen-section control, radiotherapy, and systemic therapies such as vismodegib and cemiplimab. We examined outcomes related to eyelid function, visual protection, tear drainage, and patient-reported cosmetic satisfaction. Results: MMS consistently offered high cure rates and minimal tissue loss, resulting in favorable functional and cosmetic outcomes when paired with oculoplastic reconstruction. Flap techniques such as the Hughes and Mustardé flaps showed high success rates in restoring eyelid structure and function. In advanced cases, neoadjuvant therapies reduced the need for orbital exenteration and preserved visual function in 40–60% of patients. Radiation therapy was effective but often resulted in chronic ocular surface problems. Patients undergoing exenteration reported lower satisfaction despite acceptable prosthetic rehabilitation. Conclusion: A combined approach to periocular skin cancer—integrating precise excision, functional reconstruction, and selective use of systemic therapy—yields better outcomes than single-modality treatment. Multidisciplinary planning is essential to preserve both form and function. Future studies should standardize outcome reporting and include long-term patient-centered data to guide best practices.
Referências
Arlette, J. P., Carruthers, A., Threlfall, W. J., & Warshawski, L. M. (1998). Basal cell carcinoma of the periocular region. Journal of Cutaneous Medicine and Surgery, 2(4), 205–208. https://doi.org/10.1177/120347549800200405
Avril, M. F., Auperin, A., Margulis, A., Gerbaulet, A., Duvillard, P., Benhamou, E., & ... (1997). Basal cell carcinoma of the face: Surgery or radiotherapy? Results of a randomized study. British Journal of Cancer, 76(1), 100–106. https://doi.org/10.1038/bjc.1997.343
Bartley, G. B., Garrity, J. A., Waller, R. R., Henderson, J. W., & Ilstrup, D. M. (1989). Orbital exenteration at the Mayo Clinic: 1967–1986. Ophthalmology, 96(4), 468–474. https://doi.org/10.1016/S0161-6420(89)32872-7
Bertrand, N., Guerreschi, P., Basset-Seguin, N., Saiag, P., Dupuy, A., Dalac-Rat, S., & ... (2021). Vismodegib in neoadjuvant treatment of locally advanced basal cell carcinoma: First results of a multicenter, open-label, phase 2 trial (VISMONEO study). EClinicalMedicine, 35, 100844. https://doi.org/10.1016/j.eclinm.2021.100844
Cook, B. E., Jr., & Bartley, G. B. (2001). Treatment options and future prospects for the management of eyelid malignancies: An evidence-based update. Ophthalmology, 108(11), 2088–2098.
Czyz, C. N., Cahill, K. V., Foster, J. A., Michels, K. S., Clark, C. M., & Rich, N. E. (2011). Reconstructive options for the medial canthus and eyelids following tumor excision. Saudi Journal of Ophthalmology, 25(1), 67–74. https://doi.org/10.1016/j.sjopt.2010.10.009
Essers, B., Nieman, F., Prins, M., Smeets, N., & Neumann, H. (2007). Perceptions of facial aesthetics in surgical patients with basal cell carcinoma. Journal of the European Academy of Dermatology and Venereology, 21(9), 1209–1214. https://doi.org/10.1111/j.1468-3083.2007.02227.x
Gross, N. D., Miller, D. M., Khushalani, N. I., Divi, V., Ruiz, E. S., Lipson, E. J., & ... (2022). Neoadjuvant cemiplimab for stage II to IV cutaneous squamous-cell carcinoma. The New England Journal of Medicine, 387(17), 1557–1568. https://doi.org/10.1056/NEJMoa2209813
Gulleth, Y., Goldberg, N., Silverman, R. P., & Gastman, B. R. (2010). What is the best surgical margin for a basal cell carcinoma: A meta-analysis of the literature. Plastic and Reconstructive Surgery, 126(4), 1222–1231. https://doi.org/10.1097/PRS.0b013e3181ea450d
Guo, S., Maher, E., Prat, M., et al. (2019). Periocular basal cell carcinoma—Current treatment concepts. Annals of Eye Science, 4, 4.
Hata, M., Koike, I., Omura, M., Maegawa, J., Ogino, I., & Inoue, T. (2012). Noninvasive and curative radiation therapy for sebaceous carcinoma of the eyelid. International Journal of Radiation Oncology, Biology, Physics, 82(2), 605–611. https://doi.org/10.1016/j.ijrobp.2010.12.006
Holliday, E. B., Esmaeli, B., Pinckard, J., Garden, A. S., Rosenthal, D. I., Morrison, W. H., & ... (2016). A multidisciplinary orbit-sparing treatment approach that includes proton therapy for epithelial tumors of the orbit and ocular adnexa. International Journal of Radiation Oncology, Biology, Physics, 95(1), 344–352. https://doi.org/10.1016/j.ijrobp.2016.08.008
Kahana, A., Unsworth, S. P., Andrews, C. A., Chan, M. P., Bresler, S. C., Bichakjian, C. K., & ... (2021). Vismodegib for preservation of visual function in patients with advanced periocular basal cell carcinoma: The VISORB trial. The Oncologist, 26(8), e1240–e1249. https://doi.org/10.1002/onco.13820
Karcioglu, Z. A., & Caldwell, D. R. (1984). Frozen section diagnosis in ophthalmic surgery. Survey of Ophthalmology, 28(4), 323–332. https://doi.org/10.1016/0039-6257(84)90095-X
Klingenstein, A., & Hintschich, C. (2016). The potential psychological impact of skin conditions. Clinical Dermatology, 34(5), e1–e6.
Lee, C. T., Lehrer, E. J., Aphale, A., Lango, M., Galloway, T. J., Zaorsky, N. G., & ... (2019). Surgical excision, Mohs micrographic surgery, external-beam radiotherapy, or brachytherapy for indolent skin cancer: An international meta-analysis of 58 studies with 21,000 patients. Cancer, 125(20), 3582–3594. https://doi.org/10.1002/cncr.32371
Lomas, A., Leonardi-Bee, J., & Bath-Hextall, F. (2012). A systematic review of worldwide incidence of nonmelanoma skin cancer. British Journal of Dermatology, 166(5), 1069–1080.
Martel, A., Baillif, S., Nahon-Esteve, S., Gastaud, L., Bertolotto, C., Lassalle, S., & ... (2021). Orbital exenteration: An updated review with perspectives. Survey of Ophthalmology, 66(5), 856–876. https://doi.org/10.1016/j.survophthal.2021.01.008
Mohs, F. E. (1986). Micrographic surgery for the microscopically controlled excision of eyelid cancer: History and development. Advances in Ophthalmic Plastic and Reconstructive Surgery, 5, 381–408.
Moran, J. M., & Phelps, P. O. (2020). Periocular skin cancer: Diagnosis and management. *Disease-a-Month, 66*(8), 101046. https://doi.org/10.1016/j.disamonth.2020.101046
Murchison, A. P., Walrath, J. D., Washington, C. V., et al. (2004). Techniques and outcomes of total upper and lower eyelid reconstruction: A 20-year review. Ophthalmic Plastic and Reconstructive Surgery, 20(1), 1–10.
National Comprehensive Cancer Network. (2023). NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Basal Cell Skin Cancer (Version 2.2024).
National Comprehensive Cancer Network. (2023). NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Squamous Cell Skin Cancer (Version 1.2024).
Patipa, M. (2000). Transcutaneous lower eyelid blepharoplasty with routine lateral canthal support. Facial Plastic Surgery Clinics of North America, 8(2), 523–542.
Rajak, S. N., Malhotra, R., & Selva, D. (2019). The ‘over-the-top’ modified Cutler-Beard procedure for complete upper eyelid defect reconstruction. Orbit, 38(2), 133–136. https://doi.org/10.1080/01676830.2018.1444061
Rodriguez, J. M., & Deutsch, G. P. (1992). The treatment of periocular basal cell carcinomas by radiotherapy. British Journal of Ophthalmology, 76(4), 195–197. https://doi.org/10.1136/bjo.76.4.195
Smeets, N. W., Krekels, G. A., Ostertag, J. U., et al. (2004). Mohs' micrographic surgery for treatment of basal cell carcinoma of the face—Results of a randomized controlled trial. British Journal of Dermatology, 151(4), 451–457.
Spencer, J. M., Nossa, R., & Tse, D. T. (2009). Topical imiquimod or fluorouracil therapy for basal and squamous cell carcinoma. Journal of the American Academy of Dermatology, 60(1), e1–e2.
Steren, B., Burtness, B., Bhatia, A., Demirci, H., Shinder, R., Yoo, D., & ... (2022). Cemiplimab for orbital squamous cell carcinoma in 11 cases. Ophthalmic Plastic and Reconstructive Surgery, 38(5), 496–502. https://doi.org/10.1097/IOP.0000000000002190
Tiosano, A., Ben-Ishai, M., Cnaany, Y., Markel, G., Kurman, N., Popovtzer, A., & ... (2023). Primary cemiplimab treatment for orbital squamous cell carcinoma is effective and may alleviate the need for orbital exenteration. Eye, 37(12), 2482–2487. https://doi.org/10.1038/s41433-022-02358-y
Trotier, D. C., Huang, L., Van Landingham, S. W., Burr, A. R., & T, V., MA. (2024). Review of recent advances in managing periocular skin malignancies. Frontiers in Oncology, 14. https://doi.org/10.3389/fonc.2024.1275930
Tyers, A. G. (2006). Orbital exenteration for invasive skin tumours. Eye, 20(10), 1165–1170. https://doi.org/10.1038/sj.eye.6702380
Unsworth, S. P., Tingle, C. F., Heisel, C. J., Eton, E. A., Andrews, C. A., Chan, M. P., & ... (2022). Analysis of residual disease in periocular basal cell carcinoma following hedgehog pathway inhibition: Follow up to the VISORB trial. PLOS ONE, 17(3), e0265212. https://doi.org/10.1371/journal.pone.0265212
Downloads
Publicado
Como Citar
Edição
Seção
Licença
Copyright (c) 2025 Elizabeth Arellano Pacheco, Gilberto González González, Jessica Marissa García Rodríguez , Andres Felipe Santodomingo Galindo, Lina Paola Olivero Díaz, Wendy Johana Jacome Mendoza, Lucia Margarita Franco Osorio , Verónica Cristina Lazo Jara
Este trabalho está licenciado sob uma licença Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
